Yonit Schorr
VA Boston Healthcare System
6 Papers
11 Citations
Yonit Schorr is an academic researcher from VA Boston Healthcare System. The author has contributed to research in topics: Poison control & Moral injury. The author has an hindex of 6, co-authored 6 publications. Previous affiliations of Yonit Schorr include Boston University.
Chat about Author
Papers
A randomized controlled trial of an internet-based therapist-assisted indicated preventive intervention for prolonged grief disorder
Brett T. Litz,Brett T. Litz,Yonit Schorr,Eileen Delaney,Teresa Au,Anthony Papa,Annie B. Fox,Sue E. Morris,Angela Nickerson,Susan D. Block,Holly G. Prigerson +10 more
TL;DR: HEAL has the potential to be an effective, well-tolerated tool to reduce the burden of significant pre-clinical PGD and further research is needed to refine and to assess its efficacy and mechanisms of action in a large-scale trial.
130
Sources of moral injury among war veterans: A qualitative evaluation
Yonit Schorr,Nathan Stein,Shira Maguen,Shira Maguen,J. Ben Barnes,Jeane Bosch,Brett T. Litz,Brett T. Litz +7 more
TL;DR: The aim of this qualitative study was to explore the types of events that veterans perceive as morally injurious and to use those events to develop a categorization scheme for combat-related moral injurious events.
57
Development and Validation of the Coping With Terror Scale
Nathan Stein,Yonit Schorr,Yonit Schorr,Brett T. Litz,Brett T. Litz,Lynda A. King,Lynda A. King,Daniel W. King,Daniel W. King,Zahava Solomon,Danny Horesh +10 more
TL;DR: The authors created and validated the Coping with Terror Scale to fill the measurement gap, and emphasized content validity, leveraging the knowledge of terror experts and groups of Israelis.
11
Adaptive Disclosure: An Open Trial of a Novel Exposure-Based Intervention for Service Members With Combat-Related Psychological Stress Injuries
Matt J. Gray,Yonit Schorr,William Nash,Leslie Lebowitz,Amy Amidon,Amy E. Lansing,Melissa Maglione,Ariel J. Lang,Brett T. Litz +8 more
TL;DR: Adaptive disclosure was well tolerated and, despite the brief treatment duration, promoted significant reductions in PTSD, depression, negative posttraumatic appraisals, and was also associated with increases in posttraumatic growth.